Skip to main content
Top
Published in: Medical Oncology 10/2014

01-10-2014 | Original Paper

Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population

Authors: Mehmet Burak Aktuglu, Mesut Ayer, Elif S. Bireller, Cagla Rencuzogullari, Hasan Acik, Zeynep Karaali, Taner Alioglu, Namik Yigit, Mustafa Velet, Eray Atalay, Oznur Sari Ure, Bedia Cakmakoglu

Published in: Medical Oncology | Issue 10/2014

Login to get access

Abstract

The aim of this study was to assess the possible influence of genetic polymorphisms in hOGG1, XRCC1, XRCC3, XPD, XPG and APE1 on the observed DNA damage in a group of Turkish myelodysplastic syndrome (MDS) patients. A total of 39 patients with myelodysplastic syndrome and 78 age-matched healthy control subjects were included in our study. Polymerase chain reaction/restriction fragment length polymorphism analysis was performed for the detection of DNA repair gene variants. No significant differences in DNA repair enzymes APE1, XRCC1 and XPG were found between MDS patients and controls. On the other hand, XRCC3, XPD and hOGG1 were associated with an increased risk of MDS (p = 0.004, p = 0.000, p = 0.017, respectively). Specifically, Thr/Met genotype was more relevant in patients (p = 0.026) in XRCC3; in hOGG1, Cys+ genotype was found higher in patients (p = 0.017); and in XPD, Gln/Gln genotypes were found higher in the patient (p = 0.001). In conclusion, XRCC3, XPD and hOGG1 genotypes are associated with an increased MDS risk, suggesting their possible involvement in the pathogenesis and biology of this disease.
Literature
1.
go back to reference Sterpone S, Cozzi R. Influence of XRCC1 genetic polymorphisms on ionizing radiation-induced DNA damage and repair. J Nucleic Acids. 2010;25:2010. Sterpone S, Cozzi R. Influence of XRCC1 genetic polymorphisms on ionizing radiation-induced DNA damage and repair. J Nucleic Acids. 2010;25:2010.
2.
go back to reference Altieri F, Grillo C, Maceroni M, Chichiarelli S. DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10:891–937.PubMedCrossRef Altieri F, Grillo C, Maceroni M, Chichiarelli S. DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10:891–937.PubMedCrossRef
3.
go back to reference Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res. 2008;658:215–33.PubMedCrossRef Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res. 2008;658:215–33.PubMedCrossRef
4.
go back to reference Tanrikulu S, Doğru-Abbasoğlu S, Ozderya A, et al. The 8-oxoguanine DNA N-glycosylase 1 (hOGG1) Ser326Cys variant affects the susceptibility to Graves’ disease. Cell Biochem Funct. 2011;29:244–8.PubMedCrossRef Tanrikulu S, Doğru-Abbasoğlu S, Ozderya A, et al. The 8-oxoguanine DNA N-glycosylase 1 (hOGG1) Ser326Cys variant affects the susceptibility to Graves’ disease. Cell Biochem Funct. 2011;29:244–8.PubMedCrossRef
5.
go back to reference Masson JY, Tarsounas MC, Stasiak AZ, et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001;15:3296–307.PubMedCrossRefPubMedCentral Masson JY, Tarsounas MC, Stasiak AZ, et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001;15:3296–307.PubMedCrossRefPubMedCentral
6.
go back to reference Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000;21:551–5.PubMedCrossRef Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000;21:551–5.PubMedCrossRef
7.
go back to reference Friedberg EC, Bond JP, Burns DK, et al. Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat Res. 2000;459:99–108.PubMedCrossRef Friedberg EC, Bond JP, Burns DK, et al. Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat Res. 2000;459:99–108.PubMedCrossRef
9.
go back to reference Willman CL. Molecular genetic features of myelodysplastic syndromes (MDS). Leukemia. 1998;12:S2–6.PubMed Willman CL. Molecular genetic features of myelodysplastic syndromes (MDS). Leukemia. 1998;12:S2–6.PubMed
10.
go back to reference Shin A, Lee KM, Ahn B, et al. Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev. 2008;9:501–5.PubMed Shin A, Lee KM, Ahn B, et al. Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev. 2008;9:501–5.PubMed
11.
go back to reference Fabiani E, D’Alò F, Scardocci A, et al. Polymorphisms of detoxification and DNA repair enzymes in myelodysplastic syndromes. Leuk Res. 2009;33:1068–71.PubMedCrossRef Fabiani E, D’Alò F, Scardocci A, et al. Polymorphisms of detoxification and DNA repair enzymes in myelodysplastic syndromes. Leuk Res. 2009;33:1068–71.PubMedCrossRef
13.
go back to reference Warlick ED, Smith BD. Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches. Curr Cancer Drug Targets. 2007;7:541–58.PubMedCrossRef Warlick ED, Smith BD. Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches. Curr Cancer Drug Targets. 2007;7:541–58.PubMedCrossRef
14.
go back to reference Chen H, Sandler DP, Taylor JA, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 1996;347:295–7.PubMedCrossRef Chen H, Sandler DP, Taylor JA, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 1996;347:295–7.PubMedCrossRef
15.
go back to reference Sasai Y, Horiike S, Misawa S, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res. 1999;23:975–81.PubMedCrossRef Sasai Y, Horiike S, Misawa S, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res. 1999;23:975–81.PubMedCrossRef
16.
go back to reference Tsabouri SE, Georgiou I, Alamanos I, Bourantas KL. Increased prevalence of GSTM(1) null genotype in patients with myelodysplastic syndrome: a case–control study. Acta Haematol. 2000;104:169–73.PubMedCrossRef Tsabouri SE, Georgiou I, Alamanos I, Bourantas KL. Increased prevalence of GSTM(1) null genotype in patients with myelodysplastic syndrome: a case–control study. Acta Haematol. 2000;104:169–73.PubMedCrossRef
17.
go back to reference Broberg K, Höglund M, Gustafsson C, et al. Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma. Cancer Lett. 2007;258:38–44.PubMedCrossRef Broberg K, Höglund M, Gustafsson C, et al. Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma. Cancer Lett. 2007;258:38–44.PubMedCrossRef
18.
go back to reference Belickova M, Merkerova MD, Stara E, et al. DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population. J Hematol Oncol. 2013;6:9.PubMedCrossRefPubMedCentral Belickova M, Merkerova MD, Stara E, et al. DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population. J Hematol Oncol. 2013;6:9.PubMedCrossRefPubMedCentral
19.
go back to reference Allan JM, Smith AG, Wheatley K, et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004;104:3872–7.PubMedCrossRef Allan JM, Smith AG, Wheatley K, et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004;104:3872–7.PubMedCrossRef
20.
go back to reference Voso MT, Hohaus S, Guidi F, et al. Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. Leukemia. 2008;22:1685–91.PubMedCrossRef Voso MT, Hohaus S, Guidi F, et al. Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. Leukemia. 2008;22:1685–91.PubMedCrossRef
21.
go back to reference Voso MT, D’Alo’ F, Putzulu R, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood. 2002;100:2703–7.PubMedCrossRef Voso MT, D’Alo’ F, Putzulu R, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood. 2002;100:2703–7.PubMedCrossRef
22.
go back to reference Griffin CS, Simpson PJ, Wilson CR, Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol. 2000;2:757–61.PubMedCrossRef Griffin CS, Simpson PJ, Wilson CR, Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol. 2000;2:757–61.PubMedCrossRef
23.
go back to reference Cui X, Brenneman M, Meyne J, Oshimura M, Goodwin EH, Chen DJ. The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. Mutat Res. 1999;434:75–88.PubMedCrossRef Cui X, Brenneman M, Meyne J, Oshimura M, Goodwin EH, Chen DJ. The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. Mutat Res. 1999;434:75–88.PubMedCrossRef
24.
go back to reference Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001;22:1437–45.PubMedCrossRef Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001;22:1437–45.PubMedCrossRef
25.
go back to reference Costa RM, Chiganças V, Galhardo Rda S, Carvalho H, Menck CF. The eukaryotic nucleotide excision repair pathway. Biochimie. 2003;85:1083–99.PubMedCrossRef Costa RM, Chiganças V, Galhardo Rda S, Carvalho H, Menck CF. The eukaryotic nucleotide excision repair pathway. Biochimie. 2003;85:1083–99.PubMedCrossRef
26.
go back to reference Coppedè F, Mancuso M, Lo Gerfo A, et al. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer’s disease. Neurosci Lett. 2007;414:282–5.PubMedCrossRef Coppedè F, Mancuso M, Lo Gerfo A, et al. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer’s disease. Neurosci Lett. 2007;414:282–5.PubMedCrossRef
Metadata
Title
Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population
Authors
Mehmet Burak Aktuglu
Mesut Ayer
Elif S. Bireller
Cagla Rencuzogullari
Hasan Acik
Zeynep Karaali
Taner Alioglu
Namik Yigit
Mustafa Velet
Eray Atalay
Oznur Sari Ure
Bedia Cakmakoglu
Publication date
01-10-2014
Publisher
Springer US
Published in
Medical Oncology / Issue 10/2014
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0174-6

Other articles of this Issue 10/2014

Medical Oncology 10/2014 Go to the issue